• News

"2 Peanut Patch to Treat Allergy in the Works"

  • Medscape
  • (March 02, 2015)

The daily application of a skin patch (Viaskin, DBV Technologies) that releases peanut protein is effective and safe for peanut immunotherapy, according to the largest clinical trial in peanut allergy desensitization to date. The epicutaneous immunotherapy could be "the first FDA-approved form of therapy for peanut allergy," said Hugh Sampson, MD, from the Jaffe Food Allergy Institute at the Kravis Children's Hospital at Mount Sinai in New York City. Dr. Sampson presented results from the Viaskin Peanut's Efficacy and Safety (VIPES) study here at the American Academy of Allergy, Asthma & Immunology 2015 during a late-breaking abstract session. Learn more.